Pacira Biosciences
PCRX
#5882
Rank
โ‚ฌ0.87 B
Marketcap
20,36ย โ‚ฌ
Share price
-1.15%
Change (1 day)
-3.12%
Change (1 year)
Categories

Earnings for Pacira Biosciences (PCRX)

Earnings in 2025 (TTM): โ‚ฌ39.05 Million

According to Pacira Biosciences 's latest financial reports the company's current earnings are โ‚ฌ0.71 Billion. In 2024 the company made an earning of -โ‚ฌ55.25 Million a decrease over its 2023 earnings that were of โ‚ฌ54.01 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Pacira Biosciences from 2010 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ39.05 M-170.7%
2024 -โ‚ฌ55.25 Million-202.28%
2023 โ‚ฌ54.01 M363.85%
2022 โ‚ฌ11.64 M-76.42%
2021 โ‚ฌ49.37 M180.76%
2020 โ‚ฌ17.58 M-286.92%
2019 -โ‚ฌ9.41 Million2428.94%
2018 -โ‚ฌ0.38 Million-99%
2017 -โ‚ฌ37.18 Million12.23%
2016 -โ‚ฌ33.13 Million-1885.05%
2015 โ‚ฌ1.85 M-115.65%
2014 -โ‚ฌ11.86 Million-78.95%
2013 -โ‚ฌ56.34 Million21.55%
2012 -โ‚ฌ46.35 Million41.18%
2011 -โ‚ฌ32.83 Million57.4%
2010 -โ‚ฌ20.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Zogenix
ZGNX
-โ‚ฌ0.19 Billion-606.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
โ‚ฌ3.29 M-91.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-โ‚ฌ0.11 Billion-385.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-โ‚ฌ69.5 Million-289.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-โ‚ฌ11.89 Million-132.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-โ‚ฌ54.97 Million-250.12%๐Ÿ‡บ๐Ÿ‡ธ USA